Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1972 1
1973 1
1977 1
1978 1
1981 2
1982 1
1983 1
1985 1
1986 1
1987 1
1989 1
1990 2
1991 2
1992 5
1993 1
1994 3
1996 1
1997 2
1998 1
1999 3
2001 3
2002 6
2005 3
2006 4
2007 3
2008 4
2009 5
2010 6
2011 4
2012 4
2013 3
2014 4
2015 2
2016 3
2019 3
2020 4
2021 10
2022 6
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

108 results

Results by year

Filters applied: . Clear all
Page 1
MODERN APPROACH TO DYSPEPSIA.
Medić B, Babić Ž, Banić M, Ljubičić L. Medić B, et al. Among authors: banic m. Acta Clin Croat. 2021 Dec;60(4):731-738. doi: 10.20471/acc.2021.60.04.21. Acta Clin Croat. 2021. PMID: 35734496 Free PMC article. Review.
Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis.
Sandborn WJ, Feagan BG, D'Haens G, Wolf DC, Jovanovic I, Hanauer SB, Ghosh S, Petersen A, Hua SY, Lee JH, Charles L, Chitkara D, Usiskin K, Colombel JF, Laine L, Danese S; True North Study Group. Sandborn WJ, et al. N Engl J Med. 2021 Sep 30;385(14):1280-1291. doi: 10.1056/NEJMoa2033617. N Engl J Med. 2021. PMID: 34587385 Clinical Trial.
Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis.
Sands BE, Peyrin-Biroulet L, Loftus EV Jr, Danese S, Colombel JF, Törüner M, Jonaitis L, Abhyankar B, Chen J, Rogers R, Lirio RA, Bornstein JD, Schreiber S; VARSITY Study Group. Sands BE, et al. N Engl J Med. 2019 Sep 26;381(13):1215-1226. doi: 10.1056/NEJMoa1905725. N Engl J Med. 2019. PMID: 31553834 Clinical Trial.
Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease.
Feagan BG, Sandborn WJ, Gasink C, Jacobstein D, Lang Y, Friedman JR, Blank MA, Johanns J, Gao LL, Miao Y, Adedokun OJ, Sands BE, Hanauer SB, Vermeire S, Targan S, Ghosh S, de Villiers WJ, Colombel JF, Tulassay Z, Seidler U, Salzberg BA, Desreumaux P, Lee SD, Loftus EV Jr, Dieleman LA, Katz S, Rutgeerts P; UNITI–IM-UNITI Study Group. Feagan BG, et al. N Engl J Med. 2016 Nov 17;375(20):1946-1960. doi: 10.1056/NEJMoa1602773. N Engl J Med. 2016. PMID: 27959607 Free article. Clinical Trial.
Gastric barrier function and toxic damage.
Niv Y, Banić M. Niv Y, et al. Among authors: banic m. Dig Dis. 2014;32(3):235-42. doi: 10.1159/000357855. Epub 2014 Apr 10. Dig Dis. 2014. PMID: 24732189 Review.
Historical impact to drive research in peptic ulcer disease.
Banić M, Malfertheiner P, Babić Z, Ostojić R, Kujundzic M, Fatović-Ferenčić S, Plesko S, Petričušić L. Banić M, et al. Dig Dis. 2011;29(5):444-53. doi: 10.1159/000331512. Epub 2011 Nov 16. Dig Dis. 2011. PMID: 22095008 Review.
European evidence based consensus for endoscopy in inflammatory bowel disease.
Annese V, Daperno M, Rutter MD, Amiot A, Bossuyt P, East J, Ferrante M, Götz M, Katsanos KH, Kießlich R, Ordás I, Repici A, Rosa B, Sebastian S, Kucharzik T, Eliakim R; European Crohn's and Colitis Organisation. Annese V, et al. J Crohns Colitis. 2013 Dec;7(12):982-1018. doi: 10.1016/j.crohns.2013.09.016. Epub 2013 Nov 1. J Crohns Colitis. 2013. PMID: 24184171 No abstract available.
108 results